What happens if you take a higher dose of Wegovy than prescribed?

What the clinical evidence tells us about dose and side effects

The STEP 1 trial, published in the New England Journal of Medicine, tested semaglutide 2.4 mg in nearly 2,000 adults over 68 weeks and recorded average body-weight reductions of around 15%. That result came from participants who followed the prescribed escalation, starting at 0.25 mg and stepping up roughly every four weeks. The schedule wasn't an administrative formality; it was the design that made the results achievable while keeping serious gastrointestinal side effects manageable for most people.

What this means practically: the weight-loss benefit of semaglutide comes from sustained exposure at an effective maintenance dose, not from reaching a higher number sooner. Jumping from, say, 1.0 mg to 2.4 mg in a single week does not compress months of benefit into days. It exposes your system to a concentration it hasn't had time to adapt to, which is when side effects become most likely to tip from uncomfortable into genuinely dangerous. Our page on what happens if you take the highest dose of Wegovy explains in detail what that top-of-ladder exposure looks like and why reaching it too soon carries real risk.

The NHS semaglutide guidance is explicit that dose changes must follow clinical assessment, you should never adjust timing or quantity on your own judgement. That instruction exists because the trial data supports it.

The specific risks of taking more Wegovy than prescribed

Semaglutide slows gastric emptying and acts on appetite centres in the brain. Those effects are dose-dependent: more drug, more pronounced effect, more gastric disruption. At a dose the body isn't ready for, nausea can escalate to repeated vomiting severe enough to cause dehydration and, in documented cases, require intravenous fluids in hospital.

Beyond the gastrointestinal picture, there is a more serious concern. In January 2026 the MHRA issued a Drug Safety Update highlighting acute pancreatitis as a known, infrequent but serious risk associated with GLP-1 medicines. The warning sign is severe, persistent stomach pain that may radiate into the back, with or without vomiting. Reaching too high a dose too quickly (before tolerance is built) is precisely the scenario where that kind of acute presentation is more plausible, though it can occur at any dose. Anyone experiencing that pattern of pain should seek urgent medical help and not wait.

There is also the question of what happens if you have taken a double dose accidentally rather than deliberately. If you have injected two doses in the same week, our guide on what happens if you take 2 doses of Wegovy covers the clinical picture and what steps to take. That situation has its own clinical picture, covered in detail on our page about accidentally taking a double dose of Wegovy.

What to do if your current dose feels like it isn't working

This is the question behind most queries about higher doses. You've been on your current pen for four or five weeks, the appetite suppression feels weaker than it did at first, and you're wondering whether more would help. That experience is real and recognised, semaglutide's effect on appetite can feel less dramatic once the initial adjustment settles.

The answer isn't self-escalation. The titration schedule exists partly because tolerance and therapeutic effect aren't the same thing: a dose that no longer causes nausea is still working on the biology that drives weight loss. If you genuinely feel the current dose has plateaued after a full four-week period, that conversation belongs with your prescriber. They can review your progress, check whether a clinical dose increase is appropriate, and confirm whether you're at the right point in the schedule. Think of the pen in your fridge as part of a plan, changing the plan mid-step rarely produces the outcome people hope for.

For a full overview of how the Wegovy dose ladder is structured and what each step is intended to achieve, our Wegovy doses guide walks through the schedule in detail. If you've missed a dose rather than taken extra, the guidance is different and worth reading separately, our page on what to do after a missed Wegovy dose covers that clearly.

How dose decisions work at a regulated pharmacy like ours

At nume, every dose increase requires clinical review before it's approved, that isn't a process we skip, because it's the process that keeps treatment safe. A real prescriber reads your information; no algorithm makes that call. If you're new to semaglutide treatment or thinking about transferring from another provider, our weight-loss treatment overview explains what's involved, and you can explore the full range of options at our treatment consultation page.

One note on cost: some people consider self-adjusting doses because private treatment represents a meaningful monthly outlay, and making pens stretch feels logical. The nuance around Wegovy pricing (what the private market looks like and what a legitimate price actually covers) is set out on our Wegovy cost page, if that's part of what's on your mind. But for the clinical question of whether a higher dose is right for you, the only route is a prescriber conversation. If you'd like that to happen, you can start your free consultation and have your case reviewed the same day by a GPhC-registered Independent Prescriber.